Chester County News and Community Website
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced its financial results for the fourth quarter and fiscal year 2024, alongside key updates on its MOLBREEVI program, which aims to address …
Savara Reports 2024 Financial Results and Provides Updates on MOLBREEVI Progress Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced a strategic loan and security agreement with Hercules Capital, Inc. (NYSE: HTGC), for up to $200 million. This financing strengthens Savara’s resources …
Savara Secures $200 Million Loan Agreement with Hercules Capital Read More
LANGHORNE, PA — TEN Holdings, Inc. (Nasdaq: XHLD) has released its financial results for fiscal year 2024, marking a year focused on growth initiatives and strategic transformation.
TEN Holdings Reports 2024 Financial Results and Strategic Developments Read More
NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has announced the retirement of Werner Cautreels, PhD, from his role as Chief Executive Officer, effective March 31, 2025. This leadership transition will …
Traws Pharma Announces CEO Transition as Werner Cautreels Retires Read More
WARMINSTER, PA — Havis has unveiled the SC-2000, a premium line of adaptable self-service kiosks designed to serve the diverse needs of businesses across multiple industries. Engineered with device-agnostic compatibility and …
Havis Launches SC-2000 Self-Service Kiosks for Flexible and Customizable Solutions Read More
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) has announced its financial results for the fourth quarter and fiscal year 2024, alongside significant corporate updates. The biotechnology company reaffirmed its commitment …
Arbutus Biopharma Reports 2024 Financial Results and Strategic Updates Read More NEWTON, PA — Traws Pharma, Inc. (NASDAQ: TRAW) is set to host a virtual investor event on Monday, March 31, 2025, at 10:00 AM ET, where the company will spotlight its …
Traws Pharma Announces Virtual Investor Event to Showcase Innovative Treatments for Bird Flu and COVID-19 Read More
YARDLEY, PA — Optinose (NASDAQ: OPTN) has announced its financial results for the year and quarter ending December 31, 2024, spotlighting strong growth in XHANCE prescriptions and revenue. The company also …
Optinose Reports 2024 Financial Results, Highlights Prescription Growth and First Operational Income Read More NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has unveiled promising preclinical and Phase 1 data for ratutrelvir, its investigational oral treatment for COVID-19. Presented at the International Conference for …
Traws Pharma Announces Promising Data for Ratutrelvir as a COVID-19 Treatment Read More
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) has announced its fourth-quarter and full-year 2024 financial results, highlighting unprecedented growth in revenue, gross profit, and operational milestones.
NEXGEL Reports Record-Breaking 2024 Financial Performance Read More